Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Yen Dai

Showing results (1-10 of 469) with videos related to

Pageof 47
Sort By:
Digestive Diseases and Sciences|October 27, 2010
Treatment uptake of patients with chronic hepatitis C: can we expect and do more?Chia-Yen Dai
Digestive Diseases and Sciences|February 1, 2024
Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?Batbold Batsaikhan, Chia-Yen Dai
Medicine|October 1, 2022
Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinomaTyng-Yuan Jang, Chia-Yen Dai
JAMA Otolaryngology-- Head & Neck Surgery|October 6, 2020
Association Between Hearing Impairment and Postural InstabilityNing-Chia Chang, Chia-Yen Dai
Journal of Hepatology|August 10, 2023
'One-stop-shop' point-of-care hepatitis C RNA testing intervention in the prison - some issuesChia-Yen Dai, Batbold Batsaikhan, Chung-Feng Huang
Journal of Hepatology|September 7, 2021
An EASL position paper for systemic treatment of hepatocellular carcinoma: Go forward courageouslyChia-Yen Dai, Ming-Lun Yeh, Ming-Lung Yu
Journal of Hepatology|July 10, 2022
Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: Some issuesWei-Chung Tsai, Ming-Lung Yu, Chia-Yen Dai
Journal of Hepatology|November 23, 2020
EASL recommendations on treatment of hepatitis C: Final update of the series - Some issuesChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Hepatology (Baltimore, Md.)|March 4, 2014
A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis CChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Journal of Hepatology|August 30, 2021
Predicting portal thrombosis in cirrhosis: Some issuesChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Pageof 47

Showing results (1-10 of 469) with videos related to

Sort By:
Pageof 47
Digestive Diseases and Sciences|October 27, 2010
Treatment uptake of patients with chronic hepatitis C: can we expect and do more?Chia-Yen Dai
Digestive Diseases and Sciences|February 1, 2024
Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?Batbold Batsaikhan, Chia-Yen Dai
Medicine|October 1, 2022
Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinomaTyng-Yuan Jang, Chia-Yen Dai
JAMA Otolaryngology-- Head & Neck Surgery|October 6, 2020
Association Between Hearing Impairment and Postural InstabilityNing-Chia Chang, Chia-Yen Dai
Journal of Hepatology|August 10, 2023
'One-stop-shop' point-of-care hepatitis C RNA testing intervention in the prison - some issuesChia-Yen Dai, Batbold Batsaikhan, Chung-Feng Huang
Journal of Hepatology|September 7, 2021
An EASL position paper for systemic treatment of hepatocellular carcinoma: Go forward courageouslyChia-Yen Dai, Ming-Lun Yeh, Ming-Lung Yu
Journal of Hepatology|July 10, 2022
Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: Some issuesWei-Chung Tsai, Ming-Lung Yu, Chia-Yen Dai
Journal of Hepatology|November 23, 2020
EASL recommendations on treatment of hepatitis C: Final update of the series - Some issuesChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Hepatology (Baltimore, Md.)|March 4, 2014
A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis CChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Journal of Hepatology|August 30, 2021
Predicting portal thrombosis in cirrhosis: Some issuesChia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Pageof 47